Skip to main content

TrialWire™ Technology Platform Rolls out World’s First SMS/Text Patient Contact System Across all Studies Globally


TrialWire™ Technology Platform, the most secure and rapid digital patient recruitment Platform for trial rescue, today announced the rollout of the proprietary SMS/Text Patient Engagement System across all studies globally. (Request more information here – starts in 24 hours)


The SMS/Text Patient Engagement System is a world first in speed, security, and compliance for study coordinators contacting patients to discuss their study application and site bookings.


It is primarily designed to speed up the contact process which is typically delayed using phone or email. Up to 50% of patients can be lost due to contact failure where they often don’t answer an unknown number call from a site. Study coordinators often can’t afford the time to call more than 3-4 times in the hope of connecting with the patient.


TrialWire™ always asks patients how they want to be contacted by sites and the response is that 92% of patients want to be contacted by SMS/Text so this was a driving force behind the development and rollout of the service. This includes studies for older people.


The SMS/Text system can support all languages and keeps a record in the study coordinator’s Dashboard of all conversations.


Most study coordinators are using the contact system to arrange then confirm times for calls or site screening visits.


In addition, recruitment can start in under 24-hours because the Platform doesn’t require approvals.


The Success-based Plan includes all the normal benefits from the TrialWire™ Technology Platform:

  • Dedicated secure dashboards for each Study Coordinator where they can review patient details and medical information
  • Multiple dashboards per site so all Study Coordinators can see real-time progress
  • Dashboards for sponsors and CROs where they can see de-identified referral status information
  • Secure SMS system inside their dashboards for instant communications with the patient – book calls and screening visits
  • Automated AI-Match and algorithm-driven “find and screen” patients process
  • Minute-by-minute metrics for Study Coordinators showing numbers referred, contacted, screened, and enrolled at their site
  • Minute-by-minute metrics for sponsors and CROs showing numbers referred, contacted, screened, and enrolled – across all sites on a study
  • HIPAA compliance and all patient privacy security
  • Built on the Salesforce Health Cloud
  • Unlimited number of sites globally
  • Available in all languages


Sponsored are invoiced each month for enrolled patient successes.


With more than 80% of clinical trials failing to recruit patients on time, and 30% of research sites not able to meet enrollment goals – 10% of sites don’t enroll any patients – TrialWire™ offers peace of mind for sponsors and their CROs.


TrialWire™ is ideal for sponsors and CROs wanting to avoid extended recruitment delays.


Learn more here



About TrialWire™

The TrialWire™ Platform is the most secure service (powered by Salesforce Health Cloud) that uses advanced algorithms to find the right people who are online that might be suitable for studies available on the Platform. They are invited into the Platform and taken through the AI-Match screener to determine an exact match to a study – site-based or remote/virtual. No account sign-up is required to find and apply for a study.

The Platform ingests study data from approved trial registries like ClinicalTrials.Gov.

It uses advanced online algorithms to find patient/trial matches based on detailed demographic and location profiles.

Key to the TrialWire™ success is that it finds motivated people who are actively online trying to find out more about their conditions. They can be connected to a site in under 2 minutes. These people have high retention rates.

Unlike all other digital recruitment firms, TrialWire™ does NOT keep patient details – no databases so no potential privacy breaches. Sponsors are not paying for database building where patients are sent to other studies.